07/16/2020 MYL Sentiment Algo uses 'advanced big data analytics'. This stock has potential for a significant increase in volatility . This is not a buy/sell signal
Looking for next leg in channel to fill gap and more news surrounding the COVID-19 Drug by Sanofi - With Pumper Trump having holdings here. I see this moving to target www.marketwatch.com
MYL is going to be very interesting in the weeks ahead as the "chloroquine theory" gets more testing as a COVID-19 frontline therapeutic. The stock has a Green Light from the Ichimoku Cloud and a breakout set up at $17.50/share.
The weekly chart for Mylan has broken out from a bearish trendline this week. We can see from the VPVR that there is not much volume resistance at these prices either. There is also a bullish divergence on the RSI. Relative strength has begun to improve too. The price still needs to clear both a 50-EMA & 200-EMA & bulls would want to see a golden cross occur in...
MYLAN Labs after reaching historical lows, starts exhibiting reversal signs. Next week could serve as a good confirmation signal, but at these low levels some calls with a good time to develop sound like a good idea to me. I'll check it again during pre-market Monday, and decide.
yellow lines are good spots to buy, youd set an order front running price on the yellow lines if possible. but anywhere in the yellow shaded region is aight. orange dotted is the stop loss youd wanna bail at. purple zone is good target range to cash out. purple lines a spot youd wanna frontrun a sell order a tad below. Probably would wanna take profit...
this sis highly pressed spring. MYL and ENDP in same boat. Start loading and hold for 6 months. sure 50-75% up
The price is below to 30MM. The RSI is low too. Don't buy.
The price has closed above the downtrend line started this year with consistent volumes. I opened a buy as I am expecting increasing volume and strenght in the next sessions. Tps are already highlighted on the right.
$MYL: Bullish wedge is about to be completed as yesterday we have seen rising bullish pressure, actually price wasn't able to break out the upper edge and we have seen a sharp intraday pullback (about 3%). Today buyers are coming in, thus price is heading upper edge. Volumes are rising, MACD on a weekly basis turn positive. Test of mid and long term support as...
$MYL after the earnings release has lost ground: investors actually pushed back the price yesterday with a massive bearish candle over -6%. Although the picture for generics look less positive than expected in the years to come, we should consider that demand for such goods is always "on" and today's prices (for these companies) are keeping such trend embodied....
in the chart I highlighted the last bounce from the "hystorical support" at 35,40 dollars. I drew also the main downtrend line since 12/2015. This is an interesting point because 2 solid supports pass thorugh it and price is conferming this bullish area. Earnings are expected to come in two weeks but in any case this is a tempting occasion to go long with tight...
After the breach of the multiyears downtrend prices have jumped till 47.68 dollars. We have seen a retracement according to the uptrend in progress. The price level around 39-40 is a stong support where a long can be setup. SL can be put a bit lower just underneath the MA 200 at 38 dollars. MA 200 is still under MA 50 and MACD is crossing over for a bullish...
NASDAQ:MYL is breaking out of a wedge that it has been consolidating in for nearly four years. This wedge appears to be a retest of the breakout from resistance that occurred in 2013, which was followed by a large rally during the "biotech bubble". I expect the wedge breakout to take us back to the all-time highs, at a minimum, and potentially to...
MYLAN is moving higher while TEVA and VRX is moving lower!
MYL and TEVA are under pressure again with market rally ~1.0% Only good support is for MYL at $28.75.